Cargando…
Asymmetrically designed siRNAs and shRNAs enhance the strand specificity and efficacy in RNAi
RNAi can mediate allele-specific silencing, and offers an attractive approach for treatment of human diseases caused by dominant, gain-of-function gene mutations. However, allele-specific silencing requires that the RNAi target the mutated region of the mRNA, limiting the choices of the target seque...
Autores principales: | Ding, Hongliu, Liao, Guoqing, Wang, Hongyan, Zhou, Yejin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Library Publishing Media
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737237/ https://www.ncbi.nlm.nih.gov/pubmed/19771234 |
Ejemplares similares
-
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
por: Karim, Md. Emranul, et al.
Publicado: (2018) -
Towards Antiviral shRNAs Based on the AgoshRNA Design
por: Liu, Ying Poi, et al.
Publicado: (2015) -
Generation of shRNAs from randomized oligonucleotides
por: Wu, Hailong, et al.
Publicado: (2007) -
96 shRNAs designed for maximal coverage of HIV-1 variants
por: Mcintyre, Glen John, et al.
Publicado: (2009) -
Designer siRNAs to overcome the challenges from the RNAi pathway
por: Jayasena, Sumedha D
Publicado: (2005)